{"DataElement":{"publicId":"64578","version":"3","preferredName":"Molecular Sequence Analysis Genetic Marker Mutation Text","preferredDefinition":"a text field to describe permanent change in genetic material identified by computational analysis of DNA molecules that indicate disease risk due to changed elements in gene expression regulation.","longName":"MO_SEQAN_GNMA_MUT_TX","context":"CTEP","contextVersion":"2.31","DataElementConcept":{"publicId":"2010548","version":"3","preferredName":"Molecular Sequence Analysis Genetic Marker Mutation","preferredDefinition":"related to the permanent changes in genetic material identified by computational analysis of DNA molecules that indicate risk for disease due to changed elements in regulation of gene expression.","longName":"MOL_SEQAN_GENMAR_MUT","context":"CTEP","contextVersion":"2.31","ObjectClass":{"publicId":"2497248","version":"1","preferredName":"Molecular Sequence Analysis","preferredDefinition":"Molecular; relating to or produced by or consisting of molecules.:1) Determination of the sequence of component residues in a macromolecule, e.g. amino acids in a protein or nucleotide bases in DNA/RNA.  2) Computational analysis performed to determine the similarities between nonidentical proteins or molecules of DNA or RNA.  In the case of proteins this helps identify regions involved in specific common functions (e.g. catalysis, ligand binding) or processed in a similar fashion (e.g. glycosylation, nuclear transport).  In the case of DNA/RNA, sequence analysis aids in the identification of cis-acting elements active in the regulation of gene expression or other genetic activities, or processing of RNA transcription products.","longName":"C25574:C17565","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Molecular","conceptCode":"C25574","definition":"Relating to or produced by or consisting of molecules.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Sequence Analysis","conceptCode":"C17565","definition":"The determination of the sequence of component residues in a macromolecule, e.g. amino acids in a protein or nucleotide bases in DNA/RNA or the computational analysis performed to determine the similarities between nonidentical proteins or molecules of DNA or RNA.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"18F641F3-345A-6FBD-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-07-19","endDate":null,"createdBy":"PWEST","dateCreated":"2006-07-19","modifiedBy":"ONEDATA","dateModified":"2006-07-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2497251","version":"1","preferredName":"Genetic Marker Mutation","preferredDefinition":"Alterations in DNA that may indicate an increased risk of developing a specific disease or disorder.:Genetic alterations found in the neoplastic lesions of the animal model. These alterations are not made intentionally.","longName":"C16622:C16885","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Genetic Marker","conceptCode":"C16622","definition":"A segment of DNA with an identifiable physical location on a chromosome and whose inheritance can be followed.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Mutation","conceptCode":"C16885","definition":"Genetic alterations found in the neoplastic lesions of the animal model. These alterations are not made intentionally.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"18F67010-D035-00CA-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-07-19","endDate":null,"createdBy":"PWEST","dateCreated":"2006-07-19","modifiedBy":"ONEDATA","dateModified":"2006-07-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008556","version":"1","preferredName":"Assessment Results","preferredDefinition":"the results of evaluations of the patient and the patient's disease.","longName":"ASSESS_RESULTS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B2D08DE9-38BB-7208-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-27","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-27","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"18F3BB58-F86A-1B41-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-07-19","endDate":null,"createdBy":"PWEST","dateCreated":"2006-07-19","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":"updated for ISO compliance","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2183345","version":"1","preferredName":"Assessment Results Text","preferredDefinition":"the text field to describe the results of evaluations of the patient and the patient's disease.","longName":"ASSESS_RESULTS_TXT","context":"CTEP","contextVersion":"2.31","type":"Non-enumerated","dataType":"CHARACTER","minLength":"1","maxLength":"100","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[],"ConceptualDomain":{"publicId":"2008556","version":"1","preferredName":"Assessment Results","preferredDefinition":"the results of evaluations of the patient and the patient's disease.","longName":"ASSESS_RESULTS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B2D08DE9-38BB-7208-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-27","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-27","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2184342","version":"1","preferredName":"Text","preferredDefinition":"Text; the words of something written.","longName":"Text","context":"CTEP","contextVersion":"2.31","Concepts":[{"longName":"Text","conceptCode":"C25704","definition":"The words of something written.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"DB6C8AC6-2103-3E75-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2004-05-27","endDate":null,"createdBy":"SBREXT","dateCreated":"2004-05-27","modifiedBy":"SBR","dateModified":"2005-09-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D8ADB8D8-5BC3-4A17-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2004-04-22","endDate":null,"createdBy":"PWEST","dateCreated":"2004-04-22","modifiedBy":"PWEST","dateModified":"2006-06-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2008587","version":"2","longName":"Type of Disease","context":"CTEP","ClassificationSchemeItems":[{"publicId":"2811909","version":"1","longName":"Leukemia","context":"CTEP"}]},{"publicId":"2008589","version":"2","longName":"Type of Category","context":"CTEP","ClassificationSchemeItems":[{"publicId":"2811958","version":"1","longName":"Molecular Analysis","context":"CTEP"}]},{"publicId":"2008594","version":"2.31","longName":"Trial Type Usages (CDE Disease Committees)","context":"CTEP","ClassificationSchemeItems":[{"publicId":"2811935","version":"1","longName":"Pathology Leukemia","context":"CTEP"}]}],"AlternateNames":[{"name":"OHSU Knight","type":"USED_BY","context":"OHSU Knight"},{"name":"MO_SEQAN_GNMA_MUT_TX","type":"USED_BY","context":"OHSU Knight"},{"name":"ABTC","type":"USED_BY","context":"ABTC"},{"name":"Alliance","type":"USED_BY","context":"Alliance"},{"name":"COG","type":"USED_BY","context":"COG"},{"name":"Theradex","type":"USED_BY","context":"Theradex"}],"ReferenceDocuments":[{"name":"Mutant specify","type":"Preferred Question Text","description":"Mutant specify","url":null,"context":"CTEP"},{"name":"CRF Text","type":"Alternate Question Text","description":"Sequence Analysis Mutant Type","url":null,"context":"CTEP"},{"name":"OHSU Text 1","type":"Alternate Question Text","description":"CSF3R mutation type","url":null,"context":"OHSU Knight"},{"name":"OHSU Text 2","type":"Alternate Question Text","description":"SETBP1 mutation type","url":null,"context":"OHSU Knight"},{"name":"ABTC 1604 CRF TEXT1","type":"Alternate Question Text","description":"Mutation Type","url":null,"context":"ABTC"},{"name":"COG_CRF_TEXT_1","type":"Alternate Question Text","description":"Specify which mutation(s)","url":null,"context":"COG"},{"name":"CRF Text1","type":"Alternate Question Text","description":"Name of mutation","url":null,"context":"Alliance"},{"name":"CRF Text2","type":"Alternate Question Text","description":"List any other known or suspected pathogenic mutation found","url":null,"context":"Alliance"},{"name":"CRF Text3","type":"Alternate Question Text","description":"Specify","url":null,"context":"Alliance"},{"name":"Theradex - 1","type":"Alternate Question Text","description":"Provide Specific Mutation","url":null,"context":"Theradex"}],"origin":"CTEP CDE Committee","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"18F57669-92E3-4E4E-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-07-19","endDate":null,"createdBy":"PWEST","dateCreated":"2006-07-19","modifiedBy":"MORENOC","dateModified":"2019-12-12","changeDescription":"updated for ISO compliance","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}